Skip to content
MARKETS / NYSE / FTK
NYSE · MISCELLANEOUS CHEMICAL PRODUCTS · MID CAP

Flotek Industries Inc. FTK

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$237.3M
▲ 26.9% YoY
$30.5M
▲ 190.8% YoY
In brief

What this company does

Flotek designs, develops, manufactures, packages, distributes and markets optimized chemistry solutions. As of December 31, 2025, the Company had approximately 160 total and 158 full-time employees, exclusive of existing worldwide agency relationships. As of December 31, 2025, it had 144 granted patents, including 113 patents in its CT segment and 31 patents in its DA segment. The Company's operations have two business segments, CT and DA, both supported by the Company's Research & Innovation advanced laboratory capabilities. Customers of the CT segment include energy-related companies, such as related party ProFrac Services, LLC, with which it has a long-term chemistry supply agreement, as well as industrial companies. The Company was initially incorporated under the laws of the Province of British Columbia in 1985, changed its corporate domicile to the State of Delaware in October 2001, and began trading its common stock on the New York Stock Exchange under the ticker symbol "FTK" in December 2007.

Written from the business description in Flotek Industries Inc/CN's annual report to the U.S. Securities and Exchange Commission, filed 16 March 2026. Every sentence was checked against that document before publication.

Growth
USD 237.3M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 237.3 · Net income 30.5
200M-50M-100M200920112013201520172019202120232025
Compound annual growth
+20.4%
+34.9%
−1.3%
+3.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +34.9% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
13 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 9.8% · Net 12.9%
-100%-200%200920112013201520172019202120232025
ROE
FY2025 · ROE 26.9%
50%-100%-200%-300%200920112013201520172019202120232025

Each USD of equity produced 27 cents of profit this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2022 · FCF -45.1
20M-20M-40M200920112013201520172019202120232025
Net buybacks $M Dividends $M
FY2019 · Dividends — · Net buybacks -0.0
4M8M-20M200920112013201520172019

Total assetsUSD 220.0M
EquityUSD 113.1M
CashUSD 5.7M
Gross debtUSD 40.0M
Net debtUSD 34.3M
Current ratio1.80×

Net debt stands at 30% of equity.

The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B0.20.20.20.10.00.10.10.20.20.20.30.30.40.30.30.10.1
Operating income $B0.00.00.0−0.0−0.0−0.1−0.1−0.1−0.0−0.00.00.10.10.10.0−0.0−0.0
EBITDA $B0.00.00.0−0.0−0.0−0.1−0.1−0.1−0.0−0.00.00.10.10.10.10.0−0.0
Income tax $B−0.00.00.0−0.0−0.0−0.00.0−0.00.0−0.00.00.00.0−0.00.0−0.00.0
Net income $B0.00.00.0−0.0−0.0−0.1−0.0−0.1−0.0−0.0−0.00.10.00.00.0−0.0−0.1
Free cash flow $B···−0.0−0.0−0.0−0.0−0.00.0−0.00.00.00.00.00.00.0−0.0
EPS, diluted $0.840.34−0.10−3.41−0.42−2.00−0.57−1.21−0.47−0.88−0.240.960.670.970.56−1.94−2.68
Dividend / sh $·················
Payout %·················
ROE %26.99.747.3−371.3−90.6−124.5−18.1−30.1−9.9−16.9−4.519.317.942.783.9−366.1−185.1
Shares out B0.030.030.030.010.070.070.060.060.060.060.050.050.050.050.050.04·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 80 reconciliationsAUDITED

Reconciled in 17 of 19 fiscal years. 12 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityMiscellaneous Chemical Products
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2009

Share this section

Download image